 |
|
Epidemiology of metabolic dysfunction-associated steatotic liver disease
Zobair M. Younossi, Markos Kalligeros, Linda Henry
Clin Mol Hepatol. 2025;31(Suppl):S32-S50. Published online 2024 Aug 19 DOI: https://doi.org/10.3350/cmh.2024.0431
|
|
Citations to this article as recorded by
 Association of sleep patterns and disorders with metabolic dysfunction-associated steatotic liver disease and liver fibrosis in contemporary American adults
Guannan Zong, Wangjia Mao, Ming Wen, Xiaoyun Cheng, Guanghui Liu
Annals of Hepatology.2025; 30(2): 101583. CrossRef Phthalates exposure, biological aging, and increased risks of insulin resistance, prediabetes, and diabetes in adults with metabolic dysfunction-associated steatotic liver disease
Yueru Yang, Shuhui Wan, Linling Yu, Wei Liu, Jiahao Song, Da Shi, Yongfang Zhang, Weihong Chen, Weihong Qiu, Bin Wang
Diabetes & Metabolism.2025; 51(1): 101602. CrossRef High-Intensity Interval Training Reduces Liver Enzyme Levels and Improves MASLD-Related Biomarkers in Overweight/Obese Girls
Wissal Abassi, Nejmeddine Ouerghi, Mohamed Bessem Hammami, Nidhal Jebabli, Moncef Feki, Anissa Bouassida, Katja Weiss, Beat Knechtle
Nutrients.2025; 17(1): 164. CrossRef Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD
Ester S. Alves, Jessica D. M. Santos, Alessandra G. Cruz, Felipe N. Camargo, Carlos H. Z. Talarico, Anne R. M. Santos, Carlos A. A. Silva, Henrique J. N. Morgan, Sandro L. Matos, Layanne C. C. Araujo, João Paulo Camporez
Pathophysiology.2025; 32(1): 1. CrossRef Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States
Fan Zhang, Longgen Liu, Wenjian Li
Nutrition Journal.2025;[Epub] CrossRef The association between working hours and working type with non-alcoholic fatty liver disease: results from the NHANES 1999-2014
Ruli Wang, Ningxi Wu, Huan Qu, Xiaowei Zheng, Haoyang Zhang, Lihong Zhu, Xiaolei Wang, Xiaodie Yao, Le Zhang
Frontiers in Endocrinology.2025;[Epub] CrossRef Genetic risk amplifies lifestyle effects on hepatic steatosis and its progression: Insights from a population-based cohort
Xin Zhang, Haili Wang, Chengnan Guo, Shuzhen Zhao, Yi Li, Zhenqiu Liu, Tiejun Zhang
Digestive and Liver Disease.2025;[Epub] CrossRef Tetrahydrocurcumin Alleviates Metabolic Dysfunction-Associated Steatohepatitis in Mice by Regulating Serum Lipids, Bile Acids, and Gut Microbiota
Shang Peng, Moran Meng, Ping Luo, Jiao Liu, Junjun Wang, Yong Chen
International Journal of Molecular Sciences.2025; 26(3): 895. CrossRef Novel translational mouse models of metabolic dysfunction-associated steatotic liver disease comparable to human MASLD with severe obesity
Katharina L. Hupa-Breier, Heiko Schenk, Alejandro Campos-Murguia, Freya Wellhöner, Benjamin Heidrich, Janine Dywicki, Björn Hartleben, Clara Böker, Julian Mall, Christoph Terkamp, Ludwig Wilkens, Friedrich Becker, Karl Lenhard Rudolph, Michael Peter Manns
Molecular Metabolism.2025; 93: 102104. CrossRef Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jiatong Xu, Yifan Li, Zixuan Feng, Hongping Chen
Cells.2025; 14(3): 221. CrossRef Association of high-sensitivity C-reactive protein with hepatic fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
Yunfei Wu, Guojun Zheng, Fan Zhang, Wenjian Li
Frontiers in Immunology.2025;[Epub] CrossRef Liver fibrosis progression analyzed with AI predicts renal decline
Dan-Qin Sun, Jia-Qi Shen, Xiao-Fei Tong, Ya-Yun Ren, Hai-Yang Yuan, Yang-Yang Li, Xin-Lei Wang, Sui-Dan Chen, Pei-Wu Zhu, Xiao-Dong Wang, Christopher D. Byrne, Giovanni Targher, Lai Wei, Vincent W.S. Wong, Dean Tai, Arun J. Sanyal, Hong You, Ming-Hua Zhen
JHEP Reports.2025; : 101358. CrossRef Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis
Adrian Rotaru, Remus Stafie, Ermina Stratina, Sebastian Zenovia, Robert Nastasa, Horia Minea, Laura Huiban, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Catalin Sfarti, Carol Stanciu, Anca Trifan
Life.2025; 15(2): 288. CrossRef Sex differences in diet-induced MASLD – are female mice naturally protected?
Jana Meyer, Ana Mendes Teixeira, Sandy Richter, Dean P. Larner, Asifuddin Syed, Nora Klöting, Madlen Matz-Soja, Susanne Gaul, Anja Barnikol-Oettler, Wieland Kiess, Diana Le Duc, Melanie Penke, Antje Garten
Frontiers in Endocrinology.2025;[Epub] CrossRef Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis
Tsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, Yoshihiro Kamada, Yuichiro Suzuki, Koji Sawada, Miwa Tatsuta, Tatsuji Maeshiro, Hiroshi Tobita, Takemi Akahane, Chitomi Hasebe, Miwa Kawanaka, Takaomi Kessoku, Yuichiro Eguchi, Hayashi Syokita, Atsushi Nak
Journal of Gastroenterology.2025;[Epub] CrossRef Kidney function mediates the association of per- and poly-fluoroalkyl substances (PFAS) and heavy metals with hepatic fibrosis risk
Zhengqi Wei, Jincheng Liu, Na Wang, Keke Wei
Environmental Research.2024; 263: 120092. CrossRef Assessing Mortality Disparities Among Non-Alcoholic Fatty Liver Disease Metabolic Dysfunction Fatty Liver Disease and Metabolic Dysfunction-Associated Liver Disease: A Comprehensive Meta-Analysis
Fahad Lakhdhir, Agha Syed Muhammad, Ahmed Nasir Qureshi, Imran A Shaikh, Imran Joher, Jawaria Majeed, Javaria Khan
Cureus.2024;[Epub] CrossRef Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
Clinical and Molecular Hepatology.2024; 30(4): 982. CrossRef Understanding the epidemiology of metabolic dysfunction-associated steatotic liver disease is essential for its management: need for attention to accurate diagnostic coding and classification
Han Ah Lee
The Korean Journal of Internal Medicine.2024; 39(6): 869. CrossRef AI in Hepatology: Revolutionizing the Diagnosis and Management of Liver Disease
Sheza Malik, Rishi Das, Thanita Thongtan, Kathryn Thompson, Nader Dbouk
Journal of Clinical Medicine.2024; 13(24): 7833. CrossRef
|